Skip to main content
. 2022 Nov 8;11(11):2211. doi: 10.3390/antiox11112211

Table 4.

Evolution of COVID-19 Treatment Protocol from August 2020 to July 2021.

Intervention August 2020–March 2021 June/July 2021 (Pilot Study) LUMINNOVA Upper
Respiratory Protocol
Oral MB Optional: used if symptoms were severe/delayed presentation Initially 1 mg/kg
administered 12-hourly.
Up to 2 mg/kg administered 8-hourly for a total of 8 treatments (unless contraindicated or very mild presentation).
Sublingual PBM Not utilized Initially utilized for a patient that had not adequately responded to oral MB and in a case where oral MB was contraindicated. Administered eight treatments
every 8 h or until symptoms
were resolved
Oral/nasal PDT Total of two treatment sessions 12 h apart. The number of treatment sessions gradually evolved as we observed the changes in CT values each day. Treatment course consisted of eight sessions carried out every 8 h.